| Literature DB >> 22716313 |
Patrick M Boyle1, Devin R Burrill1, Mara C Inniss1, Christina M Agapakis1,2, Aaron Deardon3, Jonathan G DeWerd3, Michael A Gedeon3, Jacqueline Y Quinn3, Morgan L Paull3, Anugraha M Raman3, Mark R Theilmann3, Lu Wang3, Julia C Winn3, Oliver Medvedik4, Kurt Schellenberg5, Karmella A Haynes1,6, Alain Viel4, Tamara J Brenner4, George M Church7,8, Jagesh V Shah1, Pamela A Silver1,7.
Abstract
BACKGROUND: Plant biotechnology can be leveraged to produce food, fuel, medicine, and materials. Standardized methods advocated by the synthetic biology community can accelerate the plant design cycle, ultimately making plant engineering more widely accessible to bioengineers who can contribute diverse creative input to the design process.Entities:
Year: 2012 PMID: 22716313 PMCID: PMC3537565 DOI: 10.1186/1754-1611-6-8
Source DB: PubMed Journal: J Biol Eng ISSN: 1754-1611 Impact factor: 4.355
Figure 1A standardized, modular system for the production of genetically-modified plants. Genetic parts (such as those obtained from the BioBrick Registry) were assembled and inserted into modified vectors (Open, Expression, or Reporter) in E. coli. These parts may be assembled to build constructs to impact a wide variety of plant phenotypes. Once assembled, these vectors were transformed into Agrobacterium. Using the floral dip procedure, Agrobacterium infected Arabidopsis, thereby transferring the assembled construct. Once seeds were produced, they were plated on selective media to obtain transgenic plants carrying the assembled construct.
Features of BioBrick plant vectors
| V1 | BBa_K382000 | kan | pat | none | none | pORE O1 |
| V2 | BBa_K382001 | kan | nptII | none | none | pORE O2 |
| V3 | BBa_K382002 | kan | pat | pENTCUP2 | none | pORE E3 |
| V4 | BBa_K382003 | kan | nptII | pENTCUP2 | none | pORE E4 |
| V5 | BBa_K382004 | kan | nptII | none | gusA | pORE R1 |
| V6 | BBa_K382005 | kan | nptII | none | smGFP | pORE R3 |
Figure 2Schematic of BioBrick plant vectors. (A) Modified Open vectors are based on vectors pORE O1 and O2 [14]. They are designed for general insertion of a construct. (B) Modified Expression vectors are based on vectors pORE E3 and E4 [14]. They contain an inducible promoter preceding the BioBrick MCS, to permit user-controlled expression of the inserted construct. (C) Modified Reporter vectors are based on vectors pORE R1 and R2 [14]. They contain a reporter gene following the BioBrick MCS, such that expression of the reporter follows that of the inserted construct.
Figure 3BioBrick miraculin and brazzein protein expression in bacteria and yeast. (A) Miraculin and (B) brazzein BioBricks were expressed from an IPTG-inducible promoter in E. coli with an N- or C-terminal Strep-II tag. Miraculin was expressed at low levels, with only a faint band appearing at 24 kDa. Brazzein was well expressed in an IPTG-dependent manner. (C) Brazzein BioBrick was expressed in yeast from pTEF or pCup1 promoters with a C- terminal Strep-II tag. Brazzein appeared larger in yeast vs. E. coli, most likely due to glycosylation of brazzein in yeast.
Figure 4BioBrick miraculin DNA and RNA expression in Arabidopsis. (A) Integration of the miraculin and brazzein genes in the Arabidopsis genome was confirmed. Primer sets for miraculin (m) and brazzein (b) demonstrated that only the desired gene was integrated. (B) Miraculin mRNA was constitutively expressed in Arabidopsis however brazzein expression was not detected. act: actin control; b: brazzein primer set; m1-m3: miraculin primer sets.